- Home
- AAME vs LGVN Comparison
AAME vs LGVN Comparison
Compare AAME & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AAME | LGVN |
|---|---|---|
| Founded | 1968 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.6M | 11.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | AAME | LGVN |
|---|---|---|
| Price | $2.70 | $0.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | 31.4K | ★ 407.0K |
| Earning Date | 11-14-2025 | 11-04-2025 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.23 | N/A |
| Revenue | ★ $208,218,000.00 | $1,437,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.69 | ★ N/A |
| Revenue Growth | ★ 11.99 | N/A |
| 52 Week Low | $1.25 | $0.50 |
| 52 Week High | $3.71 | $2.24 |
Technical Indicators
Market Signals| Indicator | AAME | LGVN |
|---|---|---|
| Relative Strength Index (RSI) | 55.49 | 29.20 |
| Support Level | $2.59 | $0.52 |
| Resistance Level | $2.96 | $0.55 |
| Average True Range (ATR) | 0.25 | 0.03 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 55.56 | 1.25 |
Price Performance
Historical ComparisonAbout AAME Atlantic American Corporation
Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.